Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Panbela Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 18 | 17 | −1 |
| Shares | 1.11M | 988.4K | −123.2K (−11.1%) |
| Value | $2.41M | $1.72M | −$692.0K (−28.7%) |
New holders (2)
Institutions that held Panbela Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Royal Bank of Canada | 500 | $1.00K | 0.00% |
| Bank of America Corp | 22 | $0 | 0.00% |
Sold out (3)
Institutions that held Panbela Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Millennium Management LLC | 32,996 | $72.0K |
| Goldman Sachs Group Inc | 23,882 | $52.0K |
| Citadel Advisors LLC | 19,682 | $43.0K |